Overview
Peter Johnson practices practicing medicine in Southampton, United Kingdom.
Mr. Johnson is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Mediastinal Tumor, B-Cell Lymphoma, and Non-Hodgkin Lymphoma.
He is actively involved in clinical research, co-authoring 173 peer reviewed articles and participating in 3 clinical trials.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Frequently Asked Questions about Peter M. Johnson
Is Peter M. Johnson a top-rated expert for Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Peter M. Johnson is classified as an Distinguished expert for Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Peter M. Johnson participate in research or clinical trials?
Yes. Peter M. Johnson has published 173 articles and abstracts on conditions like Hodgkin Lymphoma. You can view a list of Peter M. Johnson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- B-Cell LymphomaMr. Johnson isDistinguished. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Johnson isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Hodgkin LymphomaMr. Johnson isDistinguished. Learn about Hodgkin Lymphoma.
- Mediastinal TumorMr. Johnson isDistinguished. Learn about Mediastinal Tumor.
- Non-Hodgkin LymphomaMr. Johnson isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Primary Mediastinal B-Cell Lymphoma (PMBCL)Mr. Johnson isDistinguished. Learn about Primary Mediastinal B-Cell Lymphoma (PMBCL).
- Advanced
- Classical Hodgkin LymphomaMr. Johnson isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Follicular LymphomaMr. Johnson isAdvanced. Learn about Follicular Lymphoma.
- Experienced
- AgranulocytosisMr. Johnson isExperienced. Learn about Agranulocytosis.
- Breast CancerMr. Johnson isExperienced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Mr. Johnson isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Johnson isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- COVID-19Mr. Johnson isExperienced. Learn about COVID-19.
- DiarrheaMr. Johnson isExperienced. Learn about Diarrhea.